AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17339618 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human parathyroid hormone (1-84)
Number of subjects: 2532
Study 17339618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2532
Study 15028562 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg/day)
Number of subjects: 12
Study 15028562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (440 microg/day)
Number of subjects: 12
Study 15028562 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast plus Fluticasone propionate (10 mg + 440 microg/day)
Number of subjects: 12
Study 11797986 — intervention group
Group type: EXPERIMENTAL
Intervention: Long sheath
Number of subjects: 104
Study 11797986 — intervention group
Group type: COMPARATOR
Intervention: Standard sheath
Number of subjects: 104
Study 11797986 — intervention group
Group type: EXPERIMENTAL
Intervention: Long sheath (in phase 2 after standard failure)
Number of subjects: 104
Study 9726242 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 530
Study 9726242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study 9272100 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy (2 IU/m2)
Number of subjects: 27
Study 9272100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 9272100 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 27
Study 1848880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical correction with crossed intrinsic transfer
Number of subjects: 86
Study 1848880 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical correction (method not specified)
Number of subjects: 86
Study 6815696 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-azamianserin (2 mg)
Number of subjects: 11
Study 6815696 — intervention group
Group type: EXPERIMENTAL
Intervention: mianserin (6 mg)
Number of subjects: 11
Study 6815696 — intervention group
Group type: EXPERIMENTAL
Intervention: flurazepam (10 mg)
Number of subjects: 11
Study 6815696 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11
Study 6815696 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-azamianserin (0.5 and 1.0 mg of (+) and (‐) enantiomers)
Number of subjects: 11
Study 6815696 — intervention group
Group type: EXPERIMENTAL
Intervention: mianserin
Number of subjects: 11
Study 31919289 — intervention group
Group type: EXPERIMENTAL
Intervention: NICU music therapy intervention, Multimodal Neurologic Enhancement
Number of subjects: 84
Study 31919289 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study 30489382 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of oral ropinirole twice daily added on to current medication
Number of subjects: 32
Study 30489382 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily added on to current medication
Number of subjects: 32
Study 28074671 — intervention group
Group type: EXPERIMENTAL
Intervention: Illusory kinesthesia
Number of subjects: 22
Study 28074671 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study 27137507 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care delivered by a nurse practitioner (n = 94)
Number of subjects: 200
Study 27137507 — intervention group
Group type: COMPARATOR
Intervention: Services-as-usual (n = 106)
Number of subjects: 200
Study 24786357 — intervention group
Group type: EXPERIMENTAL
Intervention: 4Fr transradial coronary intervention
Number of subjects: 160
Study 24786357 — intervention group
Group type: COMPARATOR
Intervention: 6Fr transradial coronary intervention
Number of subjects: 160
Study 24786357 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study 22283962 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye of the needle technique
Number of subjects: 80
Study 22283962 — intervention group
Group type: COMPARATOR
Intervention: Triangulation method
Number of subjects: 80
Study 20386477 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense plyometric exercises
Number of subjects: 24
Study 20386477 — intervention group
Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 24
Study 18757262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant loading dose regimen (500 mg on day 0, 250 mg on days 14 and 28, then 250 mg each month thereafter)
Number of subjects: 37
Study 18757262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant loading dose regimen
Number of subjects: 37
Study 15908119 — intervention group
Group type: EXPERIMENTAL
Intervention: Four different sets of auditory stimuli (1, 2, 3, or 4 frequency bands); total range: 0-2500 Hz; only the 4-band set contained intelligible words.
Number of subjects: 0
Study 15908119 — intervention group
Group type: EXPERIMENTAL
Intervention: Most complex and most speech-like condition (4 frequency bands).
Number of subjects: 0
Study 15908119 — intervention group
Group type: COMPARATOR
Intervention: Tone-like trials (less complex conditions).
Number of subjects: 0
Study 15908119 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of presented frequency components.
Number of subjects: 0
Study 12571256 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 129
Study 12571256 — intervention group
Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 129
Study 10320237 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugal pump (CFP)
Number of subjects: 29
Study 10320237 — intervention group
Group type: COMPARATOR
Intervention: Roller pump
Number of subjects: 29
Study 9187987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB) flow rate of 2.3 L/min/m2
Number of subjects: 30
Study 9187987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB) flow rate of 1.2 L/min/m2
Number of subjects: 30
Study 9187987 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-bypass period with persistent hemodilution
Number of subjects: 30
Study 9187987 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced flow at 27 degrees C
Number of subjects: 30
Study 1553603 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 grams IV every 6 hours)
Number of subjects: 81
Study 1553603 — intervention group
Group type: COMPARATOR
Intervention: Ceftizoxime (2 grams IV every 12 hours)
Number of subjects: 81
Study 1553603 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin and Ceftizoxime
Number of subjects: 81
Study 3890463 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily whole body soap wash and umbilical cleansing with 4% chlorhexidine detergent solution (Hibiscrub)
Number of subjects: 0
Study 3890463 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily whole body soap wash and umbilical cleansing with benzine solution
Number of subjects: 0
Study 3890463 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily whole body soap wash and umbilical cleansing with 0.05% chlorhexidine
Number of subjects: 0
Study 3890463 — intervention group
Group type: COMPARATOR
Intervention: Daily whole body soap wash (control group)
Number of subjects: 0
Study 30929703 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 36
Study 30929703 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Therapy for Insomnia (MBTI)
Number of subjects: 36
Study 30929703 — intervention group
Group type: COMPARATOR
Intervention: Self‐monitoring control (SM)
Number of subjects: 36
Study 30246715 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 98
Study 30246715 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 98
Study 26561342 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 59
Study 26561342 — intervention group
Group type: COMPARATOR
Intervention: 3D conformal radiotherapy (3D-RT)
Number of subjects: 59
Study 26561342 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IMRT and 3D conformal RT
Number of subjects: 59
Study 23849907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-activity of rectus femoris
Number of subjects: 35
Study 23849907 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-activity of lateral hamstring
Number of subjects: 35
Study 23849907 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG pre-activity parameters
Number of subjects: 35
Study 22688429 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated, interactive, tailored, telephone-based health communication intervention and tailored print materials
Number of subjects: 312
Study 22688429 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 312
Study 19054631 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentives for on-time adherence (vouchers redeemable for goods)
Number of subjects: 0
Study 19054631 — intervention group
Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 0
Study 19054631 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (vouchers)
Number of subjects: 0
Study 19054631 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (vouchers)
Number of subjects: 0
Study 17305624 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulation using a device mounted on an individualized intra‐oral removable appliance for 10 minutes.
Number of subjects: 0
Study 17305624 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation for 10 minutes.
Number of subjects: 0
Study 15117900 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist leuprolide acetate followed by recombinant human FSH (r-hFSH; 100 IU/day) and hCG (2000 IU/twice a week) for 2 months (Group A1 and B1)
Number of subjects: 97
Study 15117900 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human FSH (r-hFSH) for 2 months (Group A2 and B2)
Number of subjects: 97
Study 15117900 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human FSH (r-hFSH) for 2 months (Group C)
Number of subjects: 97
Study 11250847 — intervention group
Group type: EXPERIMENTAL
Intervention: Late presenters (advanced glaucoma)
Number of subjects: 220
Study 7506160 — intervention group
Group type: EXPERIMENTAL
Intervention: nimesulide (200mg 3 times daily)
Number of subjects: 40
Study 7506160 — intervention group
Group type: COMPARATOR
Intervention: diclofenac (100mg 3 times daily)
Number of subjects: 40
Study 3552694 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose fosfomycin trometamol (3 g)
Number of subjects: 0
Study 3552694 — intervention group
Group type: COMPARATOR
Intervention: Pipemidic acid (200-gram doses b.i.d. for 7 days)
Number of subjects: 0
Study 29040357 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsible drinking messages (RDM) posters in a bar laboratory (alcohol cue rich environment)
Number of subjects: 100
Study 29040357 — intervention group
Group type: COMPARATOR
Intervention: Control posters in a bar laboratory (alcohol cue rich environment)
Number of subjects: 100
Study 29040357 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsible drinking messages (RDM) posters in a traditional laboratory (alcohol cue sparse environment)
Number of subjects: 100
Study 29040357 — intervention group
Group type: COMPARATOR
Intervention: Control posters in a traditional laboratory (alcohol cue sparse environment)
Number of subjects: 100
Study 29040357 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RDM and control posters
Number of subjects: 100
Study 29040357 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual attention to RDMs
Number of subjects: 100
Study 28659161 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 22
Study 28659161 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 22
Study 26696453 — intervention group
Group type: EXPERIMENTAL
Intervention: Provisional T-stenting
Number of subjects: 202
Study 26696453 — intervention group
Group type: COMPARATOR
Intervention: Routine T-stenting
Number of subjects: 202
Study 23558093 — intervention group
Group type: EXPERIMENTAL
Intervention: Deleobuvir 400 mg three times daily plus faldaprevir 120 mg once daily and weight-based ribavirin for 4 weeks
Number of subjects: 32
Study 23558093 — intervention group
Group type: EXPERIMENTAL
Intervention: Deleobuvir 600 mg three times daily plus faldaprevir 120 mg once daily and weight-based ribavirin for 4 weeks
Number of subjects: 32
Study 21234767 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg/min landiolol
Number of subjects: 98
Study 21234767 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg/min landiolol
Number of subjects: 98
Study 21234767 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 98
Study 18445733 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching a new word (e.g. 'whisk') paired with a novel picture, repeated exposure not specified.
Number of subjects: 0
Study 18445733 — intervention group
Group type: COMPARATOR
Intervention: Not applicable, control group of typically developing peers matched on receptive language.
Number of subjects: 0
Study 16488665 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 min pre-wash before surgical hand disinfection
Number of subjects: 44
Study 16488665 — intervention group
Group type: COMPARATOR
Intervention: No pre-wash before surgical hand disinfection
Number of subjects: 44
Study 16488665 — intervention group
Group type: EXPERIMENTAL
Intervention: No pre-wash but use of a brush for 1 min during disinfection
Number of subjects: 44
Study 16488665 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 s hand wash
Number of subjects: 44
Study 12559216 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine clinical follow up investigations within 6-18 months after first diagnosis of DCM (n=281)
Number of subjects: 480
Study 12559216 — intervention group
Group type: COMPARATOR
Intervention: Patients who did not present for routine follow up (n=153)
Number of subjects: 480
Study 12559216 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterioration of clinical status by at least one NYHA-class during follow up
Number of subjects: 480
Study 12559216 — intervention group
Group type: EXPERIMENTAL
Intervention: New onset or worsening of mitral regurgitation during follow up
Number of subjects: 480
Study 10847567 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtibial amputation
Number of subjects: 9
Study 10847567 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfemoral amputation
Number of subjects: 9
Study 9354852 — intervention group
Group type: COMPARATOR
Intervention: Insertion/deletion (I/D) polymorphism of the angiotensin-I converting enzyme gene
Number of subjects: 247
Study 8232927 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory stimulation (acupuncture) twice a week for 10 weeks
Number of subjects: 78
Study 8232927 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving daily physiotherapy and occupational therapy
Number of subjects: 78
Study 2891182 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (7.5 micrograms/min)
Number of subjects: 10
Study 2891182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30624092 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + L-PRF
Number of subjects: 16
Study 30624092 — intervention group
Group type: COMPARATOR
Intervention: OFD
Number of subjects: 16
Study 27241995 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded lingual spurs
Number of subjects: 68
Study 27241995 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional lingual spurs
Number of subjects: 68
Study 27241995 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 68
Study 26242112 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy combined with Chinese medicine (CM)
Number of subjects: 336
Study 26242112 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy
Number of subjects: 336
Study 23235956 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic ankle arthrodesis
Number of subjects: 60
Study 23235956 — intervention group
Group type: COMPARATOR
Intervention: Open ankle arthrodesis
Number of subjects: 60
Study 21051704 — intervention group
Group type: EXPERIMENTAL
Intervention: First-time trichiasis surgery
Number of subjects: 2615
Study 19330754 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic intraoperative pneumoperitoneum
Number of subjects: 60
Study 19330754 — intervention group
Group type: COMPARATOR
Intervention: Control (no pneumoperitoneum)
Number of subjects: 60
Study 16890064 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine PCA
Number of subjects: 120
Study 16890064 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine Ondansetron PCA
Number of subjects: 120
Study 16890064 — intervention group
Group type: COMPARATOR
Intervention: Placebo PCA
Number of subjects: 120
Study 14693593 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-chloroprocaine with fentanyl (20 micro g)
Number of subjects: 8
Study 14693593 — intervention group
Group type: COMPARATOR
Intervention: 2-chloroprocaine with saline (control)
Number of subjects: 8
Study 11527621 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild renal insufficiency (creatinine 1.2 mg/dl to 1.4 mg/dl)
Number of subjects: 2763
Study 11527621 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate renal insufficiency (creatinine >1.4 mg/dl)
Number of subjects: 2763
Study 11527621 — intervention group
Group type: COMPARATOR
Intervention: Normal renal function (creatinine < 1.2 mg/dl)
Number of subjects: 2763
Study 9000046 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpharmacological treatment for CFS
Number of subjects: 43
Study 9000046 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study 9000046 — intervention group
Group type: EXPERIMENTAL
Intervention: CFS patients
Number of subjects: 43
Study 8515355 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate and strenuous exercise
Number of subjects: 0
Study 8515355 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 3727591 — intervention group
Group type: EXPERIMENTAL
Intervention: 13% maltodextrin solution (52 kcal, 160 mOsm/l)
Number of subjects: 200
Study 3727591 — intervention group
Group type: COMPARATOR
Intervention: fully adapted formula (67 kcal/dl)
Number of subjects: 200
Study 3727591 — intervention group
Group type: EXPERIMENTAL
Intervention: both groups (A and B)
Number of subjects: 200
Study 31520727 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP Communication Assessment Tool (ACP-CAT)
Number of subjects: 29
Study 31520727 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP-CAT total scores
Number of subjects: 29
Study 31520727 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall impression of ACP communication skills
Number of subjects: 29
Study 31520727 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall ability to respond to emotion
Number of subjects: 29
Study 31520727 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP-CAT
Number of subjects: 29
Study 29234931 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCESS Program (group intervention)
Number of subjects: 44
Study 29234931 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 44
Study 26762368 — intervention group
Group type: EXPERIMENTAL
Intervention: Jejunal feeding
Number of subjects: 12
Study 26762368 — intervention group
Group type: COMPARATOR
Intervention: Gastric feeding
Number of subjects: 12
Study 24696417 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary angiogenin
Number of subjects: 90
Study 24696417 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary clusterin
Number of subjects: 90
Study 24696417 — intervention group
Group type: EXPERIMENTAL
Intervention: Voided urine cytology
Number of subjects: 90
Study 24696417 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined use of voided urine cytology with angiogenin and clusterin
Number of subjects: 90
Study 23644911 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 44
Study 23644911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 21122199 — intervention group
Group type: EXPERIMENTAL
Intervention: AutoPulse
Number of subjects: 85
Study 21122199 — intervention group
Group type: COMPARATOR
Intervention: Standard manual external chest compression
Number of subjects: 85
Study 19025038 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured intervention program of listening skills in quiet and in noise
Number of subjects: 20
Study 19025038 — intervention group
Group type: COMPARATOR
Intervention: Control group with no special treatment
Number of subjects: 20
Study 16164385 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower increase in HIV-related health symptoms
Number of subjects: 65
Study 16164385 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with social support
Number of subjects: 65
Study 12521598 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical alpha-tocotrienol (5% w/vol)
Number of subjects: 11
Study 12521598 — intervention group
Group type: COMPARATOR
Intervention: Vehicle-only control
Number of subjects: 11
Study 12521598 — intervention group
Group type: COMPARATOR
Intervention: Benzoyl peroxide (10%)
Number of subjects: 11
Study 10227567 — intervention group
Group type: EXPERIMENTAL
Intervention: Framingham Study risk estimates for coronary heart disease events
Number of subjects: 0
Study 10227567 — intervention group
Group type: COMPARATOR
Intervention: Dundee Risk Disk and PROCAM Study estimates
Number of subjects: 0
Study 8713558 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg alfuzosin
Number of subjects: 163
Study 8713558 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg alfuzosin
Number of subjects: 163
Study 8713558 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg alfuzosin
Number of subjects: 163
Study 8713558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 1854053 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional dose of propofol (0.7 mg.kg‐1) in group P2
Number of subjects: 50
Study 1854053 — intervention group
Group type: COMPARATOR
Intervention: Standard dose of propofol (1.5 mg.kg‐1) in group P1
Number of subjects: 50
Study 1854053 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (P1 and P2)
Number of subjects: 50
Study 6140883 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0
Study 6140883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0